AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 112.50
-5.50 (-4.66%)
Jul 9, 2026, 1:14 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 10.86 billion as of July 9, 2026. Its market cap has increased by 136.80% in one year.
Market Cap
10.86B
Enterprise Value
9.82B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
112.50
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 10.86B, an increase of 113.19%. That is a compound annual growth rate of 28.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 10.86B | -29.09% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACRO Biomedical | 12.78B |
| Gongwin Biopharm Holdings | 12.30B |
| Polaris Group | 11.91B |
| Tanvex BioPharma | 11.04B |
| Locus Cell | 9.17B |
| PharmaEngine | 9.14B |
| Acepodia | 7.87B |
| Adimmune | 7.57B |